The endocannabinoid system (ECS) is an ubiquitous lipid signalling system that plays a role in homeostasis throughout the body. Recent advances have led to the development of tools that can be used to study the physiological roles of the ECS and the potential of the ECS to be targeted in pathophysiological conditions such as chronic pain, metabolism and obesity, epilepsy and inflammation. This Special issue aims at expanding the current knowledge on the ECS in both physiological and pathological conditions. Novel experimental studies using in vitro or in vivo models, review articles consolidating recent advances, and clinical studies are welcome for consideration.
Guest Editor:
Prof. Deanne Skelly
Griffith University, Brisbane, Queensland, Australia